Literature DB >> 31960169

Difficult to treat: are there organism-dependent differences and overall risk factors in success rates for two-stage knee revision?

Martin Faschingbauer1, R Bieger2, T Kappe2, C Weiner2, T Freitag2, H Reichel2.   

Abstract

OBJECTIVES: Failure after two-stage procedure for periprosthetic joint infection (PJI) is a rare, but devastating complication. Some authors assume a correlation of underlying organisms and recurrence rate. Methicillin-resistant Staphylococci (MRS) and other organisms (quinolone-resistant Gram-negative bacteria, rifampicin-resistant Staphylococcus, Enterococcus, and Candida) are meant to be "difficult to treat" (DTT) with an inferior outcome for two-stage revision. In addition to the type of bacteria, some more risk factors seem to be present. The aim of this study was (1) to detect a difference of reinfection rates between reinfection-causing groups of bacteria ["difficult to treat" (DTT), "easy to treat" (ETT) and methicillin-resistant staphylococci (MRS)] after a two-stage procedure, and (2) find overall risk factors for reinfection in a standardized long (spacer insertion for at least 6 weeks) two-stage procedure for periprosthetic knee infection.
METHODS: One hundred and thirty-seven two-stage revisions for periprosthetic knee infection were performed at one tertiary referral center. Finally, 96 patients could be included for analyses. Possible risk factors (comorbidities, prior surgery, etc.) and the types of organisms were documented. Quinolone-resistant Gram-negative bacteria, rifampicin-resistant Staphylococcus, Enterococcus, and Candida were classified as "difficult to treat" (DTT). Methicillin-resistant Staphylococci were summarized as "MRS", all other organism are summarized as "easy to treat" (ETT). Statistical analyses included univariate analysis (t test, Fisher's exact test, Chi square test) and logistic regression analysis.
RESULTS: There were no statistical significant differences in recurrent infection rates between organism groups (DTT vs. ETT, p = 0.674; DTT vs. MRS, p = 0.705; ETT vs. MRS, p = 0.537). Risk factors seem to be "need of revision after first stage" (p = 0.019, OR 5.62) or completed second stage (p = 0.000, OR 29.07), numbers of surgeries (p = 0.028) and alcohol abuse (p = 0.019, OR 5.62).
CONCLUSIONS: Revision needed during or after a two-stage exchange, numbers of surgeries and alcohol abuse are risk factors for recurrence, a different recurrence rates between organism-groups cannot be shown. The absence of significant differences in recurrence rates points to the importance of the individuality of each periprosthetic infection case: a reduction of necessary surgeries (with a thorough debridement, appropriate antibiotic addition to spacers) and the control of comorbidities (alcohol abuse) appear to be essential components of a two-stage exchange.

Entities:  

Keywords:  Difficult to treat; Methicillin-resistant Staphylococcus aureus; Periprosthetic infection; Revision TKA; Two stage knee revision; Two-stage exchange

Mesh:

Year:  2020        PMID: 31960169     DOI: 10.1007/s00402-020-03335-4

Source DB:  PubMed          Journal:  Arch Orthop Trauma Surg        ISSN: 0936-8051            Impact factor:   3.067


  9 in total

1.  Periprosthetic joint infection is the main reason for failure in patients following periprosthetic fracture treated with revision arthroplasty.

Authors:  Janna van den Kieboom; Venkatsaiakhil Tirumala; Liang Xiong; Christian Klemt; Young-Min Kwon
Journal:  Arch Orthop Trauma Surg       Date:  2021-05-15       Impact factor: 3.067

2.  The Effect of Time Spent with a Dynamic Spacer on Clinical and Functional Outcomes in Two-Stage Revision Knee Arthroplasty.

Authors:  Fatih Golgelioglu; Sinan Oguzkaya; Abdulhamit Misir; Ahmet Guney
Journal:  Indian J Orthop       Date:  2020-09-02       Impact factor: 1.251

3.  Spacer exchange in persistent periprosthetic joint infection: microbiological evaluation and survivorship analysis.

Authors:  Antonio Clemente; Luca Cavagnaro; Antonio Russo; Francesco Chiarlone; Alessandro Massè; Giorgio Burastero
Journal:  Arch Orthop Trauma Surg       Date:  2022-01-14       Impact factor: 3.067

4.  Predictors of failure of two-stage revision in periprosthetic knee infection: a retrospective cohort study with a minimum two-year follow-up.

Authors:  Antonio Russo; Luca Cavagnaro; Francesco Chiarlone; Mattia Alessio-Mazzola; Lamberto Felli; Giorgio Burastero
Journal:  Arch Orthop Trauma Surg       Date:  2021-11-23       Impact factor: 3.067

5.  What is the rate of reinfection with different and difficult-to-treat bacteria after failed one-stage septic knee exchange?

Authors:  Mustafa Akkaya; Georges Vles; Iman Godarzi Bakhtiari; Amir Sandiford; Jochen Salber; Thorsten Gehrke; Mustafa Citak
Journal:  Int Orthop       Date:  2022-01-04       Impact factor: 3.075

6.  The Joint-Specific BACH classification: A predictor of outcome in prosthetic joint infection.

Authors:  Andrew James Hotchen; Martina Galea Wismayer; Eve Robertson-Waters; Stephen M McDonnell; Ben Kendrick; Adrian Taylor; Abtin Alvand; Martin McNally
Journal:  EClinicalMedicine       Date:  2021-11-06

7.  Significant Difference in Antimicrobial Resistance of Bacteria in Septic Revision between Total Knee Arthroplasty and Total Hip Arthroplasty.

Authors:  Stella Stevoska; Felix Himmelbauer; Julian Stiftinger; Christian Stadler; Lorenz Pisecky; Tobias Gotterbarm; Antonio Klasan
Journal:  Antibiotics (Basel)       Date:  2022-02-14

8.  Periprosthetic Fungal Infections in Severe Endoprosthetic Infections of the Hip and Knee Joint-A Retrospective Analysis of a Certified Arthroplasty Centre of Excellence.

Authors:  Andreas Enz; Silke C Mueller; Philipp Warnke; Martin Ellenrieder; Wolfram Mittelmeier; Annett Klinder
Journal:  J Fungi (Basel)       Date:  2021-05-21

Review 9.  Systematic review of risk prediction studies in bone and joint infection: are modifiable prognostic factors useful in predicting recurrence?

Authors:  Maria Dudareva; Andrew Hotchen; Martin A McNally; Jamie Hartmann-Boyce; Matthew Scarborough; Gary Collins
Journal:  J Bone Jt Infect       Date:  2021-07-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.